Concord Drugs Ltd - 538965 - Closure of Trading Window
Closure of Trading Window30-09-2022
Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome, Scrutinizer''s Report30-09-2022
Concord Drugs Ltd - 538965 - Intimation Of Book Closure Dates For 27Th Annual General Meeting.
Register of Members and Share Transfer Books of the Company shall remain closed from 24.09.2022 to 30.09.2022 (both days inclusive) for the purpose of 27th Annual General Meeting of the Company.08-09-2022
Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2021-2208-09-2022
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting07-09-2022
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Raising Of Funds For Expansion Of Business And To Explore New Options For Inorganic Growth.
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/09/2022 ,inter alia, to consider and approve Raising of funds for expansion of business and to explore new options for inorganic growth.03-09-2022
Concord Drugs Ltd - 538965 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Concord Drugs Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-08-2022
Concord Drugs Ltd - 538965 - Outcome Of 01St EGM Of The Company For The FY 2022-23.
Outcome of 01st EGM of the Company for the FY 2022-23.30-08-2022
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Unaudited Financial Resluts for the quarter ended 30.06.202216-08-2022
Concord Drugs Ltd - 538965 - Outcome Of Board Meeting For The Quarter Ended 30.06.2022
Outcome of Board meeting for the quarter ended 30.06.202213-08-2022